Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Jebbink, M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(5)
+
-
Availability
Open access
(3)
+
-
Metadata Only
(2)
+
-
Creation Date
2022
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(4)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(4)
+
-
Topic
NSCLC
(2)
+
-
Author
Jebbink, M.
(5)
+
-
Langen, A.J. de
(4)
+
-
Smit, E.F.
(4)
+
-
Noort, V. van der
(3)
+
-
Gelderblom, H.
(2)
+
-
Henegouwen, J.M.V.
(2)
+
-
Hoes, L.R.
(2)
+
-
Jansen, A.M.L.
(2)
+
-
Leng, W.W.J. de
(2)
+
-
Roepman, P.
(2)
+
-
Velden, D.L. van der
(2)
+
-
Verheul, H.M.W.
(2)
+
-
Voest, E.E.
(2)
+
-
Wekken, A.J. van der
(2)
+
-
Werkhoven, E. van
(2)
+
-
Wijngaart, H. van der
(2)
+
-
Zeverijn, L.J.
(2)
+
-
Show more
Language
en
(5)
+
-
Search results
(1 - 5 of 5)
show grid
show list
save search
Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer
Exposure-response analysis of osimertinib in EGFR mutation positive non-small cell lung cancer patients in a real-life setting
Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer
Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response
The force of HER2-A druggable target in NSCLC?